SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000926617-23-000089
Filing Date
2023-10-26
Accepted
2023-10-25 21:40:00
Documents
85
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A awh-20221231x10ka.htm   iXBRL 10-K/A 5868041
2 EX-23.1 awh-20221231xex23_1.htm EX-23.1 6478
3 EX-31.1 awh-20221231xex31_1.htm EX-31.1 23063
4 EX-31.2 awh-20221231xex31_2.htm EX-31.2 22856
5 EX-32.1 awh-20221231xex32_1.htm EX-32.1 15632
  Complete submission text file 0000926617-23-000089.txt   24142132

Data Files

Seq Description Document Type Size
6 EX-101.SCH awh-20221231.xsd EX-101.SCH 55641
7 EX-101.CAL awh-20221231_cal.xml EX-101.CAL 58632
8 EX-101.DEF awh-20221231_def.xml EX-101.DEF 264914
9 EX-101.LAB awh-20221231_lab.xml EX-101.LAB 464545
10 EX-101.PRE awh-20221231_pre.xml EX-101.PRE 506598
79 EXTRACTED XBRL INSTANCE DOCUMENT awh-20221231x10ka_htm.xml XML 7150627
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34810 | Film No.: 231347289
SIC: 2835 In Vitro & In Vivo Diagnostic Substances